COREWELL HEALTH for COREWELL HEALTH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions on Risk Adjustment. Discussions on Broadband Expansion. Discussions on potential integration with another health system. Implementation of No Surprises Act. Discussions about the 340B Prescription Drug Program. Discussions about Telehealth payments during the pandemic and post-pandemic.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BILARDELLO | — |
| PHILIP D YEITER | — |
Medicare/Medicaid MMM
Discussions on Risk Adjustment. Discussions on Broadband Expansion. Discussions on potential integration with another health system. Implementation of No Surprises Act. Discussions about the 340B Prescription Drug Program. Discussions about Telehealth payments during the pandemic and post-pandemic.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BILARDELLO | — |
| PHILIP D YEITER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.